Home › Funds › Samsara BioCapital, LLC › KLRS
Samsara BioCapital, LLC position in KLRS
KALARIS THERAPEUTICS INC · Health Care
Samsara BioCapital, LLC reported holding 12,881,175 shares of KLRS (KALARIS THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$52.4M, representing 4.31% of its reported portfolio and ranking #7 among its reported holdings. Samsara BioCapital, LLC has disclosed KLRS holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Samsara BioCapital, LLC's KLRS position evolved
Samsara BioCapital, LLC first disclosed a stake in KLRS in Q1 2025 at 11,448,081 shares (US$91.9M). The position peaked in Q4 2025 at 12,948,081 shares, worth US$109.3M. Across 6 filings, Samsara BioCapital, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 12,881,175 shares valued at US$52.4M — a reduction of -66,906 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 11.45M | $91.93M | New |
| Q2 2025 | 11.45M | $30.57M | Hold |
| Q3 2025 | 11.45M | $66.17M | Hold |
| Q4 2025 | 12.95M | $109.28M | Add |
| Q1 2026 | 12.95M | $74.71M | Hold |
| Q2 2026 | 12.88M | $52.43M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About KLRS and 13F data
KLRS (KALARIS THERAPEUTICS INC) is a Health Care company. 57 other funds we track also report a position in KLRS — the largest reported positions include WHI TRUST Co LLC (US$397K), Velan Capital Investment Management LP (US$102K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KLRS
- WHI TRUST Co LLC 97.49K sh · $396.80K · Q2 2026
- Velan Capital Investment Management LP 25.00K sh · $101.75K · Q2 2026
More on Samsara BioCapital, LLC
FAQ
How long has Samsara BioCapital, LLC held KLRS?
Samsara BioCapital, LLC has disclosed KLRS holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
What is Samsara BioCapital, LLC's current position in KLRS?
As of Q2 2026, Samsara BioCapital, LLC holds 12.88M shares of KLRS (KALARIS THERAPEUTICS INC), valued at $52.43M, representing 4.31% of its reported portfolio and ranking #7.
Has Samsara BioCapital, LLC been buying or selling KLRS?
In the latest 13F filing (Q2 2026), Samsara BioCapital, LLC reduced its position in KLRS. The position peaked in Q4 2025 at 12.95M shares.
Which other funds hold KLRS?
Other major institutional holders of KLRS include WHI TRUST Co LLC, Velan Capital Investment Management LP, among 57 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.